Volume 200, Issue 3 , Pages 283.e1-283.e7, March 2009
Abnormal fetal heart rate tracing patterns in patients with thick meconium staining of the amniotic fluid: association with perinatal outcomes
Objective
The objective of the study was to evaluate, in labors complicated by thick meconium-stained amniotic fluid, the association between specific fetal heart rate (FHR) patterns and adverse perinatal outcomes.
Study Design
A retrospective cohort study of patients with FHR tracing data (n = 1638) from a previously reported randomized controlled trial of amnioinfusion for the prevention of meconium aspiration syndrome.
Results
The presence of FHR tracing abnormalities was associated with an increased risk of perinatal mortality and/or neonatal morbidity (moderately abnormal: adjusted odds ratio [OR], 1.67; 95% confidence interval [CI], 1.18-2.37; markedly abnormal: adjusted OR, 2.97; 95% CI, 1.88-4.67). Specific abnormalities that were associated with the risk of perinatal mortality and/or neonatal morbidity included prolonged decelerations (OR, 1.22; 95% CI, 1.02-1.48), severe variable decelerations (OR, 1.08; 95% CI, 1.00-1.16), bradycardia (OR, 2.49; 95% CI, 1.02-6.11), and tachycardia (OR, 2.43; 95% CI, 1.49-3.94).
Conclusion
The presence of abnormal FHR tracing patterns in meconium-stained amniotic fluid patients is associated with an increased risk of adverse perinatal outcomes.
Key words: fetal heart rate tracing, meconium-stained amniotic fluid
To access this article, please choose from the options below
Cite this article as: Xu H, Mas-Calvet M, Wei S-Q, et al. Abnormal fetal heart rate tracing patterns in patients with thick meconium staining of the amniotic fluid: association with perinatal outcomes. Am J Obstet Gynecol 2009;200:283.e1-283.e7.
Dr Fraser receives salary support from the Canada Research Chairs Programme. Dr Luo is supported by a Junior Scholar Award from the Fonds de Recherche en Santé du Québec. Drs Xu, Calvet, and Wei were bursary recipients of the Canadian Institutes of Health Research (CIHR) Strategic Training Initiative in Research in Reproductive Health Sciences. The Amnioinfusion Trial was sponsored by a grant from CIHR.
PII: S0002-9378(08)00978-2
doi:10.1016/j.ajog.2008.08.043
© 2009 Mosby, Inc. All rights reserved.
Refers to article:
-

Abnormal fetal heart rate tracings in patients with thick meconium staining of the amniotic fluid: Xu et al
Volume 200, Issue 3 , Pages 283.e1-283.e7, March 2009
